Effects of Rosuvastatin and Aspirin on Retinal Vascular Structures in Hypercholesterolemic Patients with Low-to-Moderate Risk of Coronary Artery Disease.
Am J Cardiovasc Drugs
; 19(4): 415-420, 2019 Aug.
Article
em En
| MEDLINE
| ID: mdl-30793259
ABSTRACT
INTRODUCTION:
Atherosclerosis erodes large elastic arteries and damages peripheral small vessels. Evaluating retinal vessel caliber enables exploration of the effect of improving microcirculation with statins.OBJECTIVE:
We investigated whether rosuvastatin therapy improves retinal vasculature in hypercholesterolemic patients with a low-to-moderate risk of coronary artery disease (CAD).METHODS:
This was a prospective, open-label, randomized study in which 127 patients were enrolled and randomized (ratio 11) into rosuvastatin and control groups.RESULTS:
Rosuvastatin increased retinal arteriolar calibers by 3.560 µm at 12 months, decreased retinal venular calibers by 3.110 µm at 6 months and by 5.860 µm at 12 months, and increased the artery-vein ratio (AVR) by 2.68% at 6 months and by 5.90% at 12 months. Meanwhile, in the control group, retinal arteriolar calibers decreased by 1.110 µm at 12 months, retinal venular calibers increased by 1.020 µm at 6 months and by 1.04 µm at 12 months, and AVR decreased by 1.12% at 6 months and by 1.73% at 12 months. All the above parameters were statistically significant between groups, but there was no significant change in retinal arteriolar calibers at 6 months. The increased AVR correlated significantly with decreased C-reactive protein (CRP) at 6 months and decreased low-density lipoprotein and CRP at 12 months.DISCUSSION:
For patients with a low-to-moderate risk of CAD, we found a significant effect of rosuvastatin on retinal microvasculature, including AVR increase, venular constriction, and arteriolar dilation after 6-12 months of treatment. CLINICAL TRIAL REGISTRATION Chinese Clinical Trial Registry identifier number ChiCTR-IOR-15006664.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Vasos Retinianos
/
Doença da Artéria Coronariana
/
Aspirina
/
Rosuvastatina Cálcica
/
Hipercolesterolemia
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article